| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Smoking Cessation | 11 | 2025 | 553 | 1.470 |
Why?
|
| Hypertension | 18 | 2024 | 612 | 1.420 |
Why?
|
| Stress, Psychological | 7 | 2025 | 474 | 1.220 |
Why?
|
| Depression | 11 | 2025 | 900 | 0.990 |
Why?
|
| Female | 106 | 2025 | 34010 | 0.800 |
Why?
|
| Faculty | 1 | 2023 | 58 | 0.750 |
Why?
|
| Adult | 67 | 2025 | 17350 | 0.660 |
Why?
|
| Health Status Disparities | 3 | 2023 | 147 | 0.660 |
Why?
|
| Humans | 122 | 2025 | 65107 | 0.650 |
Why?
|
| Breast Feeding | 3 | 2025 | 166 | 0.610 |
Why?
|
| Pregnancy Complications | 5 | 2024 | 385 | 0.600 |
Why?
|
| Depression, Postpartum | 4 | 2024 | 120 | 0.590 |
Why?
|
| Social Identification | 1 | 2018 | 16 | 0.560 |
Why?
|
| Sex Factors | 9 | 2024 | 991 | 0.540 |
Why?
|
| Male | 67 | 2025 | 31039 | 0.540 |
Why?
|
| Healthcare Disparities | 6 | 2024 | 407 | 0.530 |
Why?
|
| Pregnancy | 19 | 2025 | 2372 | 0.510 |
Why?
|
| Smokers | 5 | 2025 | 117 | 0.510 |
Why?
|
| Middle Aged | 52 | 2025 | 18266 | 0.490 |
Why?
|
| Biomedical Research | 2 | 2018 | 262 | 0.490 |
Why?
|
| Socioeconomic Factors | 16 | 2025 | 801 | 0.470 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 3 | 2024 | 43 | 0.470 |
Why?
|
| United States | 34 | 2025 | 8089 | 0.460 |
Why?
|
| Cultural Competency | 1 | 2015 | 58 | 0.460 |
Why?
|
| Cardiovascular Diseases | 7 | 2025 | 863 | 0.460 |
Why?
|
| Cultural Diversity | 1 | 2015 | 54 | 0.440 |
Why?
|
| Perinatal Care | 3 | 2021 | 69 | 0.440 |
Why?
|
| Young Adult | 25 | 2025 | 4808 | 0.430 |
Why?
|
| Cross-Sectional Studies | 22 | 2022 | 2701 | 0.420 |
Why?
|
| Adolescent | 30 | 2025 | 6297 | 0.410 |
Why?
|
| Patient Education as Topic | 7 | 2018 | 481 | 0.410 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 306 | 0.400 |
Why?
|
| Blood Pressure | 6 | 2023 | 526 | 0.400 |
Why?
|
| Leisure Activities | 2 | 2012 | 26 | 0.400 |
Why?
|
| Mothers | 3 | 2025 | 280 | 0.390 |
Why?
|
| Racism | 3 | 2024 | 92 | 0.390 |
Why?
|
| Myocardial Infarction | 7 | 2015 | 919 | 0.380 |
Why?
|
| Postpartum Period | 3 | 2024 | 189 | 0.380 |
Why?
|
| Trust | 3 | 2024 | 79 | 0.370 |
Why?
|
| Health Promotion | 6 | 2025 | 516 | 0.370 |
Why?
|
| Social Determinants of Health | 3 | 2025 | 150 | 0.360 |
Why?
|
| Health Knowledge, Attitudes, Practice | 9 | 2016 | 767 | 0.360 |
Why?
|
| Motivation | 3 | 2025 | 296 | 0.350 |
Why?
|
| Text Messaging | 3 | 2025 | 97 | 0.350 |
Why?
|
| Monoclonal Gammopathy of Undetermined Significance | 2 | 2022 | 35 | 0.350 |
Why?
|
| Behavior Therapy | 4 | 2023 | 169 | 0.340 |
Why?
|
| Patient Credit and Collection | 1 | 2011 | 4 | 0.340 |
Why?
|
| Feeding Behavior | 3 | 2016 | 263 | 0.340 |
Why?
|
| Practice Patterns, Physicians' | 9 | 2015 | 706 | 0.330 |
Why?
|
| Mental Health | 3 | 2024 | 361 | 0.330 |
Why?
|
| Aged | 39 | 2025 | 14959 | 0.330 |
Why?
|
| Residence Characteristics | 4 | 2025 | 230 | 0.320 |
Why?
|
| Health Services | 1 | 2011 | 80 | 0.320 |
Why?
|
| Aflatoxin B1 | 4 | 2012 | 7 | 0.320 |
Why?
|
| Depressive Disorder | 2 | 2024 | 284 | 0.310 |
Why?
|
| Alabama | 15 | 2024 | 85 | 0.300 |
Why?
|
| Massachusetts | 10 | 2024 | 2145 | 0.300 |
Why?
|
| Medication Adherence | 3 | 2015 | 199 | 0.280 |
Why?
|
| Women's Health | 6 | 2013 | 374 | 0.280 |
Why?
|
| Health Surveys | 6 | 2018 | 316 | 0.270 |
Why?
|
| Puerto Rico | 6 | 2025 | 138 | 0.270 |
Why?
|
| Research Design | 7 | 2025 | 588 | 0.270 |
Why?
|
| Risk Factors | 15 | 2025 | 5427 | 0.260 |
Why?
|
| Brazil | 4 | 2022 | 103 | 0.260 |
Why?
|
| Contraception Behavior | 2 | 2024 | 37 | 0.260 |
Why?
|
| Social Class | 2 | 2025 | 137 | 0.260 |
Why?
|
| Diet | 4 | 2016 | 536 | 0.260 |
Why?
|
| Research Personnel | 2 | 2018 | 82 | 0.260 |
Why?
|
| Medicare | 7 | 2007 | 624 | 0.260 |
Why?
|
| Randomized Controlled Trials as Topic | 6 | 2025 | 805 | 0.260 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2020 | 496 | 0.260 |
Why?
|
| Contraception | 3 | 2024 | 72 | 0.250 |
Why?
|
| Multiple Myeloma | 2 | 2022 | 369 | 0.250 |
Why?
|
| Urban Population | 5 | 2015 | 200 | 0.250 |
Why?
|
| Patient Participation | 3 | 2019 | 234 | 0.240 |
Why?
|
| Nutrition Surveys | 5 | 2022 | 149 | 0.240 |
Why?
|
| Self Concept | 1 | 2007 | 121 | 0.240 |
Why?
|
| Health Services Accessibility | 3 | 2021 | 591 | 0.240 |
Why?
|
| Poverty | 7 | 2025 | 304 | 0.240 |
Why?
|
| Exercise | 4 | 2016 | 964 | 0.240 |
Why?
|
| Vulnerable Populations | 2 | 2025 | 94 | 0.230 |
Why?
|
| Prejudice | 2 | 2020 | 61 | 0.230 |
Why?
|
| Physician-Patient Relations | 4 | 2013 | 425 | 0.230 |
Why?
|
| Machine Learning | 2 | 2025 | 192 | 0.230 |
Why?
|
| Smoking | 5 | 2021 | 861 | 0.230 |
Why?
|
| Health Behavior | 6 | 2021 | 484 | 0.230 |
Why?
|
| Tobacco Products | 2 | 2018 | 63 | 0.220 |
Why?
|
| Coronary Artery Disease | 3 | 2016 | 324 | 0.220 |
Why?
|
| Sexual Behavior | 5 | 2021 | 191 | 0.220 |
Why?
|
| Social Support | 2 | 2008 | 391 | 0.220 |
Why?
|
| Self Report | 3 | 2023 | 390 | 0.210 |
Why?
|
| Intention | 2 | 2024 | 73 | 0.210 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2024 | 47 | 0.210 |
Why?
|
| Nursing, Practical | 1 | 2004 | 3 | 0.210 |
Why?
|
| Guideline Adherence | 2 | 2023 | 307 | 0.210 |
Why?
|
| Sexism | 1 | 2024 | 30 | 0.200 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2024 | 404 | 0.200 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2024 | 50 | 0.200 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2014 | 151 | 0.200 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2004 | 65 | 0.200 |
Why?
|
| Nursing Staff, Hospital | 1 | 2004 | 72 | 0.190 |
Why?
|
| Interpersonal Relations | 2 | 2020 | 160 | 0.190 |
Why?
|
| Prehypertension | 2 | 2013 | 2 | 0.190 |
Why?
|
| Hospital Mortality | 3 | 2004 | 875 | 0.190 |
Why?
|
| Anxiety Disorders | 1 | 2024 | 200 | 0.180 |
Why?
|
| Psychosocial Support Systems | 2 | 2019 | 12 | 0.180 |
Why?
|
| Sleep | 2 | 2016 | 240 | 0.180 |
Why?
|
| Obesity | 4 | 2016 | 1273 | 0.180 |
Why?
|
| Contraceptive Agents | 1 | 2022 | 12 | 0.180 |
Why?
|
| Paraproteinemias | 1 | 2022 | 16 | 0.180 |
Why?
|
| Food Contamination | 3 | 2012 | 23 | 0.180 |
Why?
|
| Delivery of Health Care | 5 | 2023 | 431 | 0.180 |
Why?
|
| Surveys and Questionnaires | 10 | 2022 | 2756 | 0.170 |
Why?
|
| Peer Influence | 1 | 2021 | 6 | 0.170 |
Why?
|
| Hepatitis C, Chronic | 1 | 2022 | 89 | 0.170 |
Why?
|
| Community Health Services | 2 | 2014 | 127 | 0.170 |
Why?
|
| Self Efficacy | 3 | 2014 | 205 | 0.170 |
Why?
|
| Cognition | 2 | 2017 | 508 | 0.170 |
Why?
|
| Communication | 4 | 2021 | 596 | 0.170 |
Why?
|
| Patient Selection | 4 | 2018 | 485 | 0.160 |
Why?
|
| Vegetables | 2 | 2000 | 68 | 0.160 |
Why?
|
| Hepatitis C | 1 | 2022 | 144 | 0.160 |
Why?
|
| Fruit | 2 | 2000 | 101 | 0.160 |
Why?
|
| Child Nutrition Sciences | 1 | 2000 | 4 | 0.160 |
Why?
|
| Cluster Analysis | 3 | 2019 | 261 | 0.160 |
Why?
|
| Neoplasms | 3 | 2017 | 1367 | 0.160 |
Why?
|
| Knowledge | 2 | 2018 | 32 | 0.160 |
Why?
|
| Allostasis | 1 | 2020 | 10 | 0.160 |
Why?
|
| Informed Consent | 2 | 2018 | 141 | 0.150 |
Why?
|
| Qualitative Research | 1 | 2024 | 750 | 0.150 |
Why?
|
| Adolescent Behavior | 4 | 2009 | 192 | 0.150 |
Why?
|
| Adaptation, Psychological | 4 | 2025 | 279 | 0.150 |
Why?
|
| Program Evaluation | 3 | 2018 | 493 | 0.150 |
Why?
|
| Electronic Health Records | 1 | 2023 | 393 | 0.150 |
Why?
|
| Psychological Techniques | 1 | 2019 | 5 | 0.150 |
Why?
|
| Community Health Workers | 2 | 2018 | 41 | 0.150 |
Why?
|
| Longitudinal Studies | 6 | 2025 | 1282 | 0.150 |
Why?
|
| Minority Groups | 2 | 2018 | 141 | 0.150 |
Why?
|
| Time Factors | 9 | 2025 | 3762 | 0.140 |
Why?
|
| Social Theory | 1 | 2018 | 7 | 0.140 |
Why?
|
| Social Media | 1 | 2021 | 127 | 0.140 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2005 | 202 | 0.140 |
Why?
|
| Logistic Models | 7 | 2024 | 1269 | 0.140 |
Why?
|
| Program Development | 2 | 2018 | 208 | 0.140 |
Why?
|
| Blood Glucose | 2 | 2020 | 497 | 0.140 |
Why?
|
| Patient Compliance | 2 | 2014 | 367 | 0.140 |
Why?
|
| Social Segregation | 1 | 2018 | 10 | 0.140 |
Why?
|
| Mobile Applications | 1 | 2020 | 140 | 0.140 |
Why?
|
| Follow-Up Studies | 7 | 2023 | 2483 | 0.140 |
Why?
|
| Capacity Building | 1 | 2018 | 23 | 0.140 |
Why?
|
| Advance Directives | 1 | 2018 | 49 | 0.130 |
Why?
|
| Consumer Health Information | 1 | 2018 | 36 | 0.130 |
Why?
|
| Stress, Physiological | 1 | 2020 | 210 | 0.130 |
Why?
|
| Culturally Competent Care | 1 | 2018 | 17 | 0.130 |
Why?
|
| Income | 3 | 2022 | 169 | 0.130 |
Why?
|
| Chronic Disease | 2 | 2025 | 742 | 0.130 |
Why?
|
| Police | 1 | 2018 | 37 | 0.130 |
Why?
|
| Referral and Consultation | 3 | 2014 | 443 | 0.130 |
Why?
|
| Spirituality | 1 | 2018 | 43 | 0.130 |
Why?
|
| Community-Based Participatory Research | 1 | 2018 | 62 | 0.130 |
Why?
|
| Models, Psychological | 2 | 2008 | 101 | 0.130 |
Why?
|
| Advance Care Planning | 1 | 2018 | 68 | 0.130 |
Why?
|
| Bipolar Disorder | 1 | 2019 | 249 | 0.130 |
Why?
|
| Overweight | 2 | 2016 | 257 | 0.130 |
Why?
|
| Psychometrics | 2 | 2017 | 392 | 0.130 |
Why?
|
| Simulation Training | 1 | 2018 | 66 | 0.130 |
Why?
|
| Sexual Health | 1 | 2016 | 8 | 0.130 |
Why?
|
| Self-Management | 1 | 2018 | 71 | 0.130 |
Why?
|
| Educational Status | 4 | 2013 | 277 | 0.120 |
Why?
|
| Research Subjects | 1 | 2017 | 41 | 0.120 |
Why?
|
| Workplace | 1 | 2018 | 177 | 0.120 |
Why?
|
| Health Care Coalitions | 2 | 2006 | 2 | 0.120 |
Why?
|
| Hospitalization | 4 | 2015 | 1392 | 0.120 |
Why?
|
| Mother-Child Relations | 1 | 2016 | 45 | 0.120 |
Why?
|
| Community Health Planning | 2 | 2006 | 16 | 0.120 |
Why?
|
| Age Factors | 5 | 2024 | 1585 | 0.120 |
Why?
|
| Pandemics | 1 | 2021 | 674 | 0.120 |
Why?
|
| Community Participation | 2 | 2006 | 48 | 0.120 |
Why?
|
| Weight Loss | 2 | 2016 | 276 | 0.120 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 702 | 0.120 |
Why?
|
| Directive Counseling | 2 | 2006 | 39 | 0.120 |
Why?
|
| Weight Reduction Programs | 1 | 2016 | 63 | 0.120 |
Why?
|
| Research | 1 | 2017 | 194 | 0.110 |
Why?
|
| Mass Screening | 3 | 2017 | 698 | 0.110 |
Why?
|
| Motor Activity | 2 | 2009 | 345 | 0.110 |
Why?
|
| Fertility | 1 | 2015 | 84 | 0.110 |
Why?
|
| Child | 7 | 2023 | 4607 | 0.110 |
Why?
|
| Odds Ratio | 6 | 2018 | 754 | 0.110 |
Why?
|
| Mental Recall | 1 | 2015 | 95 | 0.110 |
Why?
|
| Patient Discharge | 2 | 2015 | 519 | 0.110 |
Why?
|
| Comorbidity | 6 | 2022 | 1119 | 0.110 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2014 | 7 | 0.110 |
Why?
|
| Schools | 2 | 2009 | 169 | 0.100 |
Why?
|
| Product Labeling | 1 | 2013 | 9 | 0.100 |
Why?
|
| Social Discrimination | 1 | 2014 | 13 | 0.100 |
Why?
|
| Risk Assessment | 5 | 2024 | 2102 | 0.100 |
Why?
|
| Amblyopia | 2 | 2010 | 2 | 0.100 |
Why?
|
| Rural Population | 4 | 2011 | 223 | 0.100 |
Why?
|
| Primary Health Care | 2 | 2010 | 721 | 0.100 |
Why?
|
| Mental Disorders | 2 | 2020 | 822 | 0.100 |
Why?
|
| Drug Monitoring | 1 | 2015 | 202 | 0.100 |
Why?
|
| Biomarkers | 5 | 2022 | 1480 | 0.100 |
Why?
|
| Aged, 80 and over | 8 | 2020 | 5612 | 0.100 |
Why?
|
| Weight Gain | 1 | 2014 | 166 | 0.100 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2014 | 78 | 0.100 |
Why?
|
| Cohort Studies | 7 | 2020 | 2619 | 0.100 |
Why?
|
| Health Status | 3 | 2024 | 447 | 0.100 |
Why?
|
| Diabetes, Gestational | 1 | 2015 | 142 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 731 | 0.090 |
Why?
|
| Capsule Endoscopy | 1 | 2013 | 40 | 0.090 |
Why?
|
| Smoking Prevention | 1 | 2013 | 163 | 0.090 |
Why?
|
| Multivariate Analysis | 5 | 2016 | 930 | 0.090 |
Why?
|
| Lysine | 1 | 2012 | 94 | 0.090 |
Why?
|
| Mammography | 3 | 2010 | 290 | 0.090 |
Why?
|
| Tobacco Use Disorder | 1 | 2014 | 248 | 0.090 |
Why?
|
| Developing Countries | 1 | 2012 | 87 | 0.090 |
Why?
|
| Acute Coronary Syndrome | 1 | 2015 | 253 | 0.090 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2013 | 88 | 0.090 |
Why?
|
| Infant, Newborn | 3 | 2025 | 1422 | 0.090 |
Why?
|
| Culture | 3 | 2011 | 82 | 0.090 |
Why?
|
| Hospitals, Teaching | 2 | 2004 | 105 | 0.090 |
Why?
|
| Cultural Characteristics | 2 | 2018 | 38 | 0.090 |
Why?
|
| Cognition Disorders | 1 | 2013 | 223 | 0.090 |
Why?
|
| Health Services Research | 3 | 2018 | 265 | 0.090 |
Why?
|
| Thrombolytic Therapy | 2 | 2005 | 195 | 0.090 |
Why?
|
| Calcinosis | 1 | 2012 | 84 | 0.090 |
Why?
|
| Patient Readmission | 1 | 2015 | 448 | 0.090 |
Why?
|
| Technology | 2 | 2022 | 53 | 0.090 |
Why?
|
| Prevalence | 3 | 2024 | 1445 | 0.090 |
Why?
|
| Emergency Service, Hospital | 2 | 2022 | 1149 | 0.090 |
Why?
|
| Family Practice | 2 | 2003 | 215 | 0.080 |
Why?
|
| Videodisc Recording | 1 | 2011 | 8 | 0.080 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 2010 | 6 | 0.080 |
Why?
|
| Heart Failure | 2 | 2013 | 957 | 0.080 |
Why?
|
| Education, Medical, Continuing | 3 | 2010 | 92 | 0.080 |
Why?
|
| Health Services Needs and Demand | 2 | 2009 | 219 | 0.080 |
Why?
|
| Life Change Events | 1 | 2011 | 66 | 0.080 |
Why?
|
| Breast Neoplasms | 4 | 2010 | 1222 | 0.080 |
Why?
|
| Counseling | 3 | 2014 | 375 | 0.080 |
Why?
|
| Mental Health Services | 1 | 2014 | 304 | 0.080 |
Why?
|
| Infant | 3 | 2024 | 1693 | 0.080 |
Why?
|
| Poisons | 1 | 2009 | 2 | 0.080 |
Why?
|
| Tunica Media | 1 | 2009 | 6 | 0.080 |
Why?
|
| Tunica Intima | 1 | 2009 | 16 | 0.080 |
Why?
|
| Focus Groups | 2 | 2024 | 319 | 0.080 |
Why?
|
| Anxiety | 2 | 2024 | 426 | 0.080 |
Why?
|
| Hospitals | 2 | 2022 | 387 | 0.080 |
Why?
|
| Carotid Arteries | 1 | 2009 | 64 | 0.070 |
Why?
|
| Carotid Artery Diseases | 1 | 2009 | 61 | 0.070 |
Why?
|
| Anemia | 1 | 2010 | 132 | 0.070 |
Why?
|
| Physical Education and Training | 1 | 2009 | 29 | 0.070 |
Why?
|
| Environment Design | 1 | 2009 | 23 | 0.070 |
Why?
|
| Vaginal Douching | 1 | 2008 | 3 | 0.070 |
Why?
|
| Vision Screening | 1 | 2008 | 9 | 0.070 |
Why?
|
| Health Education | 3 | 2013 | 189 | 0.070 |
Why?
|
| Emigrants and Immigrants | 1 | 2008 | 47 | 0.070 |
Why?
|
| Pregnancy Outcome | 1 | 2009 | 197 | 0.070 |
Why?
|
| Women | 1 | 2008 | 43 | 0.070 |
Why?
|
| Professional-Patient Relations | 1 | 2008 | 127 | 0.070 |
Why?
|
| Token Economy | 1 | 2007 | 7 | 0.070 |
Why?
|
| Child Health Services | 1 | 2008 | 68 | 0.070 |
Why?
|
| Reproducibility of Results | 3 | 2017 | 1698 | 0.060 |
Why?
|
| Chlamydia Infections | 2 | 2005 | 79 | 0.060 |
Why?
|
| Alcohol Drinking | 1 | 2010 | 322 | 0.060 |
Why?
|
| Cocaine-Related Disorders | 1 | 2007 | 81 | 0.060 |
Why?
|
| Diabetes Complications | 1 | 2007 | 106 | 0.060 |
Why?
|
| Prognosis | 3 | 2016 | 1784 | 0.060 |
Why?
|
| Prospective Studies | 5 | 2018 | 3308 | 0.060 |
Why?
|
| Aflatoxin M1 | 1 | 2006 | 1 | 0.060 |
Why?
|
| Healthy People Programs | 1 | 2006 | 11 | 0.060 |
Why?
|
| Gastrointestinal Diseases | 2 | 2003 | 69 | 0.060 |
Why?
|
| Carcinogens | 1 | 2006 | 33 | 0.060 |
Why?
|
| Incidence | 4 | 2013 | 1419 | 0.060 |
Why?
|
| Ghana | 3 | 2012 | 14 | 0.060 |
Why?
|
| Fee-for-Service Plans | 2 | 2004 | 71 | 0.060 |
Why?
|
| Internet | 2 | 2010 | 466 | 0.060 |
Why?
|
| Total Quality Management | 2 | 2003 | 56 | 0.060 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2006 | 55 | 0.060 |
Why?
|
| Food Handling | 1 | 2006 | 59 | 0.060 |
Why?
|
| Self Disclosure | 1 | 2005 | 37 | 0.060 |
Why?
|
| Glucose Intolerance | 1 | 2006 | 90 | 0.060 |
Why?
|
| Ambulatory Care | 2 | 2013 | 317 | 0.060 |
Why?
|
| Medical Records | 1 | 2005 | 140 | 0.060 |
Why?
|
| Sexually Transmitted Diseases | 2 | 2006 | 95 | 0.050 |
Why?
|
| Chlamydia trachomatis | 1 | 2005 | 60 | 0.050 |
Why?
|
| Sampling Studies | 2 | 2005 | 65 | 0.050 |
Why?
|
| Parity | 1 | 2025 | 71 | 0.050 |
Why?
|
| Pregnancy in Adolescence | 1 | 2004 | 21 | 0.050 |
Why?
|
| Goals | 2 | 2020 | 96 | 0.050 |
Why?
|
| Chi-Square Distribution | 3 | 2015 | 413 | 0.050 |
Why?
|
| Fibrinolytic Agents | 1 | 2005 | 178 | 0.050 |
Why?
|
| Safety Management | 1 | 2005 | 136 | 0.050 |
Why?
|
| Life Style | 3 | 2015 | 321 | 0.050 |
Why?
|
| Complementary Therapies | 1 | 2004 | 63 | 0.050 |
Why?
|
| Resilience, Psychological | 1 | 2025 | 66 | 0.050 |
Why?
|
| Kidney Diseases | 1 | 2005 | 177 | 0.050 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2004 | 129 | 0.050 |
Why?
|
| Hospitals, Urban | 1 | 2004 | 44 | 0.050 |
Why?
|
| Disease Progression | 2 | 2022 | 1220 | 0.050 |
Why?
|
| Quality of Health Care | 2 | 2015 | 528 | 0.050 |
Why?
|
| Parent-Child Relations | 2 | 2004 | 66 | 0.050 |
Why?
|
| Drug Utilization Review | 1 | 2003 | 50 | 0.050 |
Why?
|
| Choice Behavior | 1 | 2024 | 85 | 0.050 |
Why?
|
| Education, Nursing | 1 | 2004 | 41 | 0.050 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2003 | 29 | 0.050 |
Why?
|
| Peer Review, Health Care | 1 | 2003 | 16 | 0.050 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2003 | 47 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2025 | 587 | 0.050 |
Why?
|
| Angina, Unstable | 1 | 2003 | 56 | 0.050 |
Why?
|
| Medicaid | 2 | 2022 | 372 | 0.050 |
Why?
|
| Medical Staff, Hospital | 1 | 2003 | 59 | 0.050 |
Why?
|
| Managed Care Programs | 1 | 2003 | 86 | 0.050 |
Why?
|
| Rheumatology | 1 | 2003 | 70 | 0.050 |
Why?
|
| Child, Preschool | 3 | 2016 | 2061 | 0.050 |
Why?
|
| Fluorenes | 1 | 2022 | 13 | 0.050 |
Why?
|
| Sofosbuvir | 1 | 2022 | 16 | 0.050 |
Why?
|
| Sterilization, Reproductive | 1 | 2022 | 10 | 0.050 |
Why?
|
| Oral Health | 1 | 2003 | 64 | 0.050 |
Why?
|
| Internal Medicine | 1 | 2003 | 154 | 0.050 |
Why?
|
| Antidepressive Agents | 1 | 2024 | 233 | 0.050 |
Why?
|
| Demography | 3 | 2010 | 178 | 0.050 |
Why?
|
| Drug Utilization | 1 | 2003 | 204 | 0.040 |
Why?
|
| Students | 1 | 2004 | 224 | 0.040 |
Why?
|
| Carbon Monoxide | 1 | 2022 | 63 | 0.040 |
Why?
|
| Benzimidazoles | 1 | 2022 | 56 | 0.040 |
Why?
|
| Cooperative Behavior | 2 | 2018 | 229 | 0.040 |
Why?
|
| Hematologic Tests | 1 | 2001 | 16 | 0.040 |
Why?
|
| Systole | 2 | 2012 | 109 | 0.040 |
Why?
|
| Cardiology | 1 | 2003 | 170 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2003 | 285 | 0.040 |
Why?
|
| Tobacco Smoking | 1 | 2021 | 19 | 0.040 |
Why?
|
| Linear Models | 2 | 2015 | 405 | 0.040 |
Why?
|
| Bias | 1 | 2001 | 115 | 0.040 |
Why?
|
| Physical Examination | 1 | 2001 | 109 | 0.040 |
Why?
|
| Urban Health | 2 | 2015 | 40 | 0.040 |
Why?
|
| Hepacivirus | 1 | 2022 | 133 | 0.040 |
Why?
|
| Georgia | 2 | 2015 | 90 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2022 | 463 | 0.040 |
Why?
|
| Leadership | 1 | 2003 | 211 | 0.040 |
Why?
|
| Outpatients | 1 | 2022 | 142 | 0.040 |
Why?
|
| Cost of Illness | 2 | 2015 | 169 | 0.040 |
Why?
|
| Benchmarking | 1 | 2001 | 137 | 0.040 |
Why?
|
| HIV Infections | 2 | 2004 | 955 | 0.040 |
Why?
|
| Diabetes Mellitus | 2 | 2005 | 555 | 0.040 |
Why?
|
| Nutritional Sciences | 1 | 2000 | 32 | 0.040 |
Why?
|
| Data Collection | 2 | 2014 | 382 | 0.040 |
Why?
|
| Forecasting | 2 | 2014 | 230 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2020 | 142 | 0.040 |
Why?
|
| Hospitals, Maternity | 1 | 2019 | 10 | 0.040 |
Why?
|
| Puerperal Disorders | 1 | 2019 | 15 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2020 | 159 | 0.040 |
Why?
|
| Reward | 1 | 2020 | 89 | 0.040 |
Why?
|
| Postnatal Care | 1 | 2020 | 43 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2022 | 321 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2014 | 497 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2016 | 897 | 0.040 |
Why?
|
| Medically Underserved Area | 2 | 2010 | 31 | 0.040 |
Why?
|
| Vaccination | 1 | 2001 | 377 | 0.030 |
Why?
|
| Teaching Materials | 1 | 2018 | 12 | 0.030 |
Why?
|
| Women, Working | 1 | 2018 | 9 | 0.030 |
Why?
|
| Decision Making | 2 | 2017 | 417 | 0.030 |
Why?
|
| Prenatal Care | 1 | 2020 | 169 | 0.030 |
Why?
|
| Diffusion of Innovation | 1 | 2018 | 58 | 0.030 |
Why?
|
| Risk Reduction Behavior | 1 | 2018 | 121 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2013 | 5789 | 0.030 |
Why?
|
| Oncology Nursing | 1 | 2017 | 15 | 0.030 |
Why?
|
| Health Literacy | 1 | 2018 | 87 | 0.030 |
Why?
|
| Confidentiality | 1 | 2017 | 58 | 0.030 |
Why?
|
| Retrospective Studies | 5 | 2013 | 6863 | 0.030 |
Why?
|
| Sex Education | 1 | 2016 | 27 | 0.030 |
Why?
|
| Reference Values | 1 | 2017 | 327 | 0.030 |
Why?
|
| Career Choice | 1 | 2018 | 125 | 0.030 |
Why?
|
| Nutritive Value | 1 | 2016 | 37 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2016 | 125 | 0.030 |
Why?
|
| Community-Institutional Relations | 2 | 2006 | 42 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2016 | 101 | 0.030 |
Why?
|
| Energy Intake | 1 | 2016 | 173 | 0.030 |
Why?
|
| Health Care Surveys | 2 | 2009 | 288 | 0.030 |
Why?
|
| Attitude to Health | 2 | 2008 | 296 | 0.030 |
Why?
|
| Behavioral Risk Factor Surveillance System | 2 | 2005 | 45 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2015 | 236 | 0.030 |
Why?
|
| Hospital Volunteers | 1 | 2014 | 2 | 0.030 |
Why?
|
| Volunteers | 1 | 2014 | 17 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 1015 | 0.030 |
Why?
|
| Medical Audit | 2 | 2005 | 67 | 0.030 |
Why?
|
| Medically Uninsured | 2 | 2004 | 46 | 0.030 |
Why?
|
| Quality of Life | 2 | 2015 | 1260 | 0.030 |
Why?
|
| Patient Navigation | 1 | 2014 | 36 | 0.030 |
Why?
|
| Recurrence | 1 | 2015 | 657 | 0.020 |
Why?
|
| Toilet Facilities | 1 | 2012 | 4 | 0.020 |
Why?
|
| Vascular Malformations | 1 | 2013 | 22 | 0.020 |
Why?
|
| Survival Rate | 1 | 2015 | 844 | 0.020 |
Why?
|
| Risk | 1 | 2013 | 374 | 0.020 |
Why?
|
| Maternal Exposure | 1 | 2012 | 43 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2014 | 179 | 0.020 |
Why?
|
| Body Weight | 1 | 2014 | 376 | 0.020 |
Why?
|
| Patient-Centered Care | 1 | 2015 | 256 | 0.020 |
Why?
|
| Drug Prescriptions | 2 | 2003 | 164 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2013 | 291 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 1559 | 0.020 |
Why?
|
| Southeastern United States | 1 | 2011 | 26 | 0.020 |
Why?
|
| Quality Indicators, Health Care | 2 | 2005 | 346 | 0.020 |
Why?
|
| Vision Tests | 1 | 2010 | 9 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 1163 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2012 | 163 | 0.020 |
Why?
|
| Random Allocation | 1 | 2010 | 200 | 0.020 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2009 | 25 | 0.020 |
Why?
|
| Stillbirth | 1 | 2009 | 18 | 0.020 |
Why?
|
| Physicians, Primary Care | 1 | 2010 | 78 | 0.020 |
Why?
|
| Infant, Low Birth Weight | 1 | 2009 | 59 | 0.020 |
Why?
|
| Software | 1 | 2013 | 400 | 0.020 |
Why?
|
| Length of Stay | 1 | 2013 | 827 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2012 | 361 | 0.020 |
Why?
|
| Time Management | 1 | 2008 | 8 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2008 | 101 | 0.020 |
Why?
|
| Day Care, Medical | 1 | 2007 | 4 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2009 | 199 | 0.020 |
Why?
|
| Rehabilitation, Vocational | 1 | 2007 | 32 | 0.020 |
Why?
|
| Reimbursement Mechanisms | 1 | 2007 | 41 | 0.020 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2007 | 89 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2007 | 372 | 0.020 |
Why?
|
| Arachis | 1 | 2006 | 5 | 0.020 |
Why?
|
| Waist-Hip Ratio | 1 | 2006 | 12 | 0.020 |
Why?
|
| Social Change | 1 | 2006 | 13 | 0.020 |
Why?
|
| State Government | 1 | 2006 | 32 | 0.010 |
Why?
|
| Zea mays | 1 | 2006 | 30 | 0.010 |
Why?
|
| Albumins | 1 | 2006 | 43 | 0.010 |
Why?
|
| Research Support as Topic | 1 | 2006 | 42 | 0.010 |
Why?
|
| Health Priorities | 1 | 2006 | 29 | 0.010 |
Why?
|
| Life Tables | 1 | 2005 | 23 | 0.010 |
Why?
|
| Peptic Ulcer | 1 | 2005 | 18 | 0.010 |
Why?
|
| Cytoprotection | 1 | 2005 | 18 | 0.010 |
Why?
|
| Vaginal Smears | 1 | 2006 | 59 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2006 | 252 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 1 | 2007 | 252 | 0.010 |
Why?
|
| Creatinine | 1 | 2005 | 135 | 0.010 |
Why?
|
| Epidemiologic Methods | 1 | 2005 | 67 | 0.010 |
Why?
|
| Lipids | 1 | 2007 | 328 | 0.010 |
Why?
|
| Specialization | 1 | 2005 | 82 | 0.010 |
Why?
|
| Medicine | 1 | 2005 | 53 | 0.010 |
Why?
|
| Cardiovascular Agents | 1 | 2005 | 106 | 0.010 |
Why?
|
| Jamaica | 1 | 2004 | 2 | 0.010 |
Why?
|
| Social Values | 1 | 2004 | 16 | 0.010 |
Why?
|
| Coronary Disease | 1 | 2005 | 246 | 0.010 |
Why?
|
| Vitamins | 1 | 2004 | 80 | 0.010 |
Why?
|
| Religion and Psychology | 1 | 2004 | 11 | 0.010 |
Why?
|
| Epidemiological Monitoring | 1 | 2003 | 32 | 0.010 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2004 | 51 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2005 | 285 | 0.010 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2003 | 48 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2005 | 740 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 20 | 0.010 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2003 | 22 | 0.010 |
Why?
|
| Dental Care | 1 | 2003 | 6 | 0.010 |
Why?
|
| Rural Health | 1 | 2003 | 16 | 0.010 |
Why?
|
| Unemployment | 1 | 2003 | 19 | 0.010 |
Why?
|
| Insurance, Health | 1 | 2004 | 151 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2003 | 61 | 0.010 |
Why?
|
| Medicare Part A | 1 | 2003 | 7 | 0.010 |
Why?
|
| Risk-Taking | 1 | 2004 | 159 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2005 | 223 | 0.010 |
Why?
|
| Arthritis | 1 | 2003 | 52 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2003 | 130 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 2003 | 94 | 0.010 |
Why?
|
| Age Distribution | 1 | 2003 | 262 | 0.010 |
Why?
|
| Environmental Monitoring | 1 | 2003 | 154 | 0.010 |
Why?
|
| Models, Organizational | 1 | 2003 | 91 | 0.010 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2003 | 140 | 0.010 |
Why?
|
| Bone Density | 1 | 2003 | 142 | 0.010 |
Why?
|
| Insulin | 1 | 2006 | 695 | 0.010 |
Why?
|
| Needs Assessment | 1 | 2003 | 201 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2005 | 883 | 0.010 |
Why?
|
| Trichomonas Vaginitis | 1 | 2001 | 7 | 0.010 |
Why?
|
| Diabetic Foot | 1 | 2001 | 11 | 0.010 |
Why?
|
| Feedback | 1 | 2001 | 91 | 0.010 |
Why?
|
| Radiography | 1 | 2003 | 555 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 1113 | 0.010 |
Why?
|
| Influenza Vaccines | 1 | 2001 | 97 | 0.010 |
Why?
|
| Food Services | 1 | 2000 | 25 | 0.010 |
Why?
|
| Cholesterol | 1 | 2001 | 261 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2005 | 726 | 0.010 |
Why?
|
| Triglycerides | 1 | 2001 | 248 | 0.010 |
Why?
|
| Inservice Training | 1 | 2000 | 85 | 0.010 |
Why?
|
| Gonorrhea | 1 | 2001 | 162 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2000 | 309 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2003 | 734 | 0.010 |
Why?
|
| Family | 1 | 2000 | 245 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2003 | 624 | 0.010 |
Why?
|
| Algorithms | 1 | 2003 | 1048 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2003 | 918 | 0.010 |
Why?
|
| Curriculum | 1 | 2000 | 608 | 0.010 |
Why?
|